Statement from FDA Commissioner Scott Gottlieb, M.D., On New Steps To Help Prevent New Addiction, Curb Abuse and Overdose Related to Opioid Products

no thumb

Statement from the Commissioner of the U.S. Food and Drug Administration (FDA) on the agency’s efforts to address the opioid epidemic, including new packaging intended to reduce new addiction and the release of the Opioid Analgesic REMS Education Blueprint for Health Care Providers Involved in the Treatment and Monitoring of Patients with Pain.

Source link


The author admin

Leave a Response